Notably, the expression pattern PD-L1 (-)Siglec-15(+) accounted for the vast majority (76.67%) of 60 glioma patients, and PD-L1(+) expression pattern was detected in only 16.67% of glioma tissues. The gene discussed is CD274; the disease is central nervous system cancer.